35.22 USD
+2.67 (+8.2%)
35.22 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 86% to STOK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 33.02. This target is -6.24% below the current price.
STOK was analyzed by 16 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about STOK.
In the previous month the buy percentage consensus was at a similar level.
STOK was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2026-01-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-05 | BTIG | Reiterate | Buy -> Buy |
| 2025-11-05 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-11-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-03 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-13 | BTIG | Maintains | Buy -> Buy |
| 2025-10-10 | Needham | Maintains | Buy -> Buy |
| 2025-08-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-13 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-07-18 | Jefferies | Initiate | Buy |
| 2025-07-01 | Needham | Reiterate | Buy -> Buy |
| 2025-05-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-03-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-18 | Needham | Reiterate | Buy -> Buy |
| 2025-02-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-18 | Needham | Reiterate | Buy -> Buy |
| 2025-02-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-08 | Needham | Maintains | Buy -> Buy |
| 2025-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-20 | Chardan Capital | Initiate | Buy |
| 2024-12-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-06 | Needham | Reiterate | Buy -> Buy |
| 2024-11-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-08 | Needham | Reiterate | Buy -> Buy |
| 2024-07-11 | Wedbush | Reiterate | Outperform -> Outperform |
STOKE THERAPEUTICS INC / STOK FAQ
Can you provide the average price target for STOKE THERAPEUTICS INC stock?
16 analysts have analysed STOK and the average price target is 33.02 USD. This implies a price decrease of -6.24% is expected in the next year compared to the current price of 35.22.
How do analysts rate STOKE THERAPEUTICS INC (STOK)?
The consensus rating for STOKE THERAPEUTICS INC (STOK) is 86.25 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for STOK stock?
The number of analysts covering STOKE THERAPEUTICS INC (STOK) is 16.